NCT05733390View on ClinicalTrials.gov

A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

June 30, 2023

Primary Completion Date

November 9, 2023

Study Completion Date

November 9, 2023

Conditions

Irritability Associated With Autism Spectrum DisorderAutism Spectrum DisorderASD

Interventions

DRUG

JZP541

Oral suspension

OTHER

Placebo

Oral suspension

Trial Locations (1)

10461

Albert Einstein College of Medicine, The Bronx

Sponsors

Lead Sponsor

Jazz Pharmaceuticals

Collaborators (1)

All Listed Sponsors

collaborator

GW Research

UNKNOWN

lead

Jazz Pharmaceuticals

INDUSTRY